These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 32505607)

  • 1. Resection of a desmoid-type fibromatosis with a CTNNB1 p.S45P mutation using a cervico-thoracic approach: A case report and literature review.
    Sato R; Bandoh N; Goto T; Uemura A; Inoue N; Otomo Y; Nakano H; Yamaguchi T; Kato Y; Nishihara H; Takei H; Harabuchi Y
    Auris Nasus Larynx; 2021 Aug; 48(4):777-782. PubMed ID: 32505607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological features of 70 desmoid-type fibromatoses confirmed by β-catenin immunohistochemical staining and CTNNB1 mutation analysis.
    An J; Woo HY; Lee Y; Kim HS; Jeong J; Kim SK
    PLoS One; 2021; 16(4):e0250619. PubMed ID: 33914771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifocal occurrence of extra-abdominal desmoid type fibromatosis - A rare manifestation. A clinicopathological study of 6 sporadic cases and 1 hereditary case.
    Bekers EM; van Broekhoven DLM; van Dalen T; Bonenkamp JJ; van der Geest ICM; de Rooy JWJ; van Gorp JM; Creytens DH; de Leng WWJ; Scheijen B; Eijkelenboom A; Flucke U
    Ann Diagn Pathol; 2018 Aug; 35():38-41. PubMed ID: 29705714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lower Rate of CTNNB1 Mutations and Higher Rate of APC Mutations in Desmoid Fibromatosis of the Breast: A Series of 134 Tumors.
    Norkowski E; Masliah-Planchon J; Le Guellec S; Trassard M; Courrèges JB; Charron-Barra C; Terrier P; Bonvalot S; Coindre JM; Laé M
    Am J Surg Pathol; 2020 Sep; 44(9):1266-1273. PubMed ID: 32590455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinicopathological and molecular genetic features of neuromuscular choristoma-associated desmoid type fibromatosis].
    Dong RF; Guo W; Li N; Wang ZY; Sun XQ; Ding Y
    Zhonghua Bing Li Xue Za Zhi; 2024 Jul; 53(7):685-690. PubMed ID: 38955699
    [No Abstract]   [Full Text] [Related]  

  • 6. Novel pathogenic alterations in pediatric and adult desmoid-type fibromatosis - A systematic analysis of 204 cases.
    Trautmann M; Rehkämper J; Gevensleben H; Becker J; Wardelmann E; Hartmann W; Grünewald I; Huss S
    Sci Rep; 2020 Feb; 10(1):3368. PubMed ID: 32099073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiation-induced Sarcomas Occurring in Desmoid-type Fibromatosis Are Not Always Derived From the Primary Tumor.
    Verschoor AJ; Cleton-Jansen AM; Wijers-Koster P; Coffin CM; Lazar AJ; Nout RA; Rubin BP; Gelderblom H; Bovée JV
    Am J Surg Pathol; 2015 Dec; 39(12):1701-7. PubMed ID: 26414222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical staining with non-phospho β-catenin as a diagnostic and prognostic tool of COX-2 inhibitor therapy for patients with extra-peritoneal desmoid-type fibromatosis.
    Sakai T; Nishida Y; Hamada S; Koike H; Ikuta K; Ota T; Ishiguro N
    Diagn Pathol; 2017 Aug; 12(1):66. PubMed ID: 28851389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adipocyte-rich
    Bakker A; Slack JC; Caragea M; Kurek KC; Bründler MA
    Pediatr Dev Pathol; 2021; 24(1):62-67. PubMed ID: 33104413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. β-Catenin mutation status and outcomes in sporadic desmoid tumors.
    Mullen JT; DeLaney TF; Rosenberg AE; Le L; Iafrate AJ; Kobayashi W; Szymonifka J; Yeap BY; Chen YL; Harmon DC; Choy E; Yoon SS; Raskin KA; Hornicek FJ; Nielsen GP
    Oncologist; 2013; 18(9):1043-9. PubMed ID: 23960186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical application of next-generation sequencing for the management of desmoid tumors: A case report and literature review.
    Lee JM; Kim HG; Shin SY; Lee SH
    Medicine (Baltimore); 2021 Jan; 100(1):e24238. PubMed ID: 33429825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Droplet Digital PCR (ddPCR) as a Novel Technology in Detecting CTNNB1 Mutations in Desmoid Fibromatosis.
    Gandhi J; Kao E; Wu Y; Mantilla JG; Ricciotti RW; Bandhlish A; Liu YJ; Chen EY
    Appl Immunohistochem Mol Morphol; 2022 Nov-Dec 01; 30(10):662-667. PubMed ID: 36227098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic desmoid-type fibromatosis with beta-catenin gene mutation-Report of a case and review of the literature.
    Tsukamoto Y; Imakita M; Nishitani A; Ito T; Izukura M; Hirota S
    Pathol Res Pract; 2016 May; 212(5):484-9. PubMed ID: 26907785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is immunohistochemical staining for β-catenin the definitive pathological diagnostic tool for desmoid-type fibromatosis? A multi-institutional study.
    Koike H; Nishida Y; Kohno K; Shimoyama Y; Motoi T; Hamada S; Kawai A; Ogose A; Ozaki T; Kunisada T; Matsumoto Y; Matsunobu T; Ae K; Gokita T; Sakai T; Shimizu K; Ishiguro N
    Hum Pathol; 2019 Feb; 84():155-163. PubMed ID: 30292627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aggressive fibromatosis of the head and neck (desmoid tumours).
    Abdelkader M; Riad M; Williams A
    J Laryngol Otol; 2001 Oct; 115(10):772-6. PubMed ID: 11667985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CTNNB1 S45F mutation predicts poor efficacy of meloxicam treatment for desmoid tumors: a pilot study.
    Hamada S; Futamura N; Ikuta K; Urakawa H; Kozawa E; Ishiguro N; Nishida Y
    PLoS One; 2014; 9(5):e96391. PubMed ID: 24788118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Next-generation sequencing is highly sensitive for the detection of beta-catenin mutations in desmoid-type fibromatoses.
    Aitken SJ; Presneau N; Kalimuthu S; Dileo P; Berisha F; Tirabosco R; Amary MF; Flanagan AM
    Virchows Arch; 2015 Aug; 467(2):203-10. PubMed ID: 25838078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intra-abdominal desmoid fibromatosis mimicking tumour recurrence after the operation: A case series.
    Nam KH; Kim B
    Malays J Pathol; 2023 Apr; 45(1):111-122. PubMed ID: 37119251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late Presentation of Aggressive Fibromatosis Involving Head, Neck and Chest Wall.
    Hajjar WM; AlShehri AF; Alessa MA; Al-Nassar SA
    J Coll Physicians Surg Pak; 2017 Oct; 27(10):654-656. PubMed ID: 29056131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the usefulness of nuclear beta-catenin in the diagnosis of desmoid-type fibromatosis among commonly used anti-beta-catenin antibodies.
    Yamada Y; Hirata M; Sakamoto A; Noguchi T; Ito K; Nishida Y; Matsuda S; Haga H
    Pathol Int; 2021 Jun; 71(6):392-399. PubMed ID: 33788979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.